首页> 美国卫生研究院文献>Translational Psychiatry >Epigenetic differences in monozygotic twins discordant for major depressive disorder
【2h】

Epigenetic differences in monozygotic twins discordant for major depressive disorder

机译:重症抑郁症患者单卵双胎的表观遗传差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although monozygotic (MZ) twins share the majority of their genetic makeup, they can be phenotypically discordant on several traits and diseases. DNA methylation is an epigenetic mechanism that can be influenced by genetic, environmental and stochastic events and may have an important impact on individual variability. In this study we explored epigenetic differences in peripheral blood samples in three MZ twin studies on major depressive disorder (MDD). Epigenetic data for twin pairs were collected as part of a previous study using 8.1-K-CpG microarrays tagging DNA modification in white blood cells from MZ twins discordant for MDD. Data originated from three geographical regions: UK, Australia and the Netherlands. Ninety-seven MZ pairs (194 individuals) discordant for MDD were included. Different methods to address non independently-and-identically distributed (non-i.i.d.) data were evaluated. Machine-learning methods with feature selection centered on support vector machine and random forest were used to build a classifier to predict cases and controls based on epivariations. The most informative variants were mapped to genes and carried forward for network analysis. A mixture approach using principal component analysis (PCA) and Bayes methods allowed to combine the three studies and to leverage the increased predictive power provided by the larger sample. A machine-learning algorithm with feature reduction classified affected from non-affected twins above chance levels in an independent training-testing design. Network analysis revealed gene networks centered on the PPAR−γ (NR1C3) and C-MYC gene hubs interacting through the AP-1 (c-Jun) transcription factor. PPAR−γ (NR1C3) is a drug target for pioglitazone, which has been shown to reduce depression symptoms in patients with MDD. Using a data-driven approach we were able to overcome challenges of non-i.i.d. data when combining epigenetic studies from MZ twins discordant for MDD. Individually, the studies yielded negative results but when combined classification of the disease state from blood epigenome alone was possible. Network analysis revealed genes and gene networks that support the inflammation hypothesis of MDD.
机译:尽管单卵双胞胎(MZ)双胞胎拥有大部分的遗传构成,但在某些性状和疾病上可能表现出表型不一致。 DNA甲基化是一种表观遗传机制,可能会受到遗传,环境和随机事件的影响,并且可能对个体变异性产生重要影响。在这项研究中,我们探讨了三项关于重度抑郁症(MDD)的MZ双胞胎研究中外周血样本的表观遗传学差异。作为先前研究的一部分,使用8.1-K-CpG微阵列收集了成对双胞胎的表观遗传数据,该芯片在来自MZ双胞胎的MDD不一致的白细胞中标记DNA修饰。数据来自三个地理区域:英国,澳大利亚和荷兰。包括与MDD不符的97对MZ对(194个人)。评估了解决非独立且相同分布的(non.i.d.)数据的不同方法。使用以支持向量机和随机森林为中心的特征选择的机器学习方法来构建分类器,以基于表观变异预测情况和控制。将信息最丰富的变异体定位到基因,并进行网络分析。使用主成分分析(PCA)和贝叶斯方法的混合方法可以将这三个研究结合起来,并利用较大样本提供的增加的预测能力。在独立训练测试设计中,一种机器学习算法,其中特征归类归因于机会水平以上的未受影响双胞胎的影响。网络分析显示基因网络集中在通过AP-1(c-Jun)转录因子相互作用的PPAR-γ(NR1C3)和C-MYC基因集线器上。 PPAR-γ(NR1C3)是吡格列酮的药物靶标,已显示可减轻MDD患者的抑郁症状。使用数据驱动的方法,我们能够克服非i.d.的挑战。结合MZ双胞胎对MDD不一致的表观遗传研究时的数据。单独地,这些研究得出了阴性结果,但是当仅根据血液表观基因组对疾病状态进行合并分类是可能的。网络分析揭示了支持MDD炎症假说的基因和基因网络。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号